Muhammed Masum Canat
Muhammed Masum Canat has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Yüksel Altuntaş
Sisli Etfal Training and Research Hospital, Department of Endocrinology and Metabolism, Istanbul, Türkiye
5 shared publications - Feyza Yener Öztürk
Sisli Etfal Training and Research Hospital, Department of Endocrinology and Metabolism, Istanbul, Türkiye
3 shared publications - Adnan Batman
Division of Endocrinology and Metabolism, Department of Internal Medicine, Acibadem University School of Medicine, Istanbul, Türkiye
2 shared publications - Hasan Anıl Atalay
Department of Urology, Okmeydanı Training and Research Hospital, Sisli-Istanbul, Turkey
2 shared publications - Alper Baba
Department of International Water Resources, Izmir Institute of Technology, 35430 Izmir, Türkiye
1 shared publication - Betul Kaymak Toru
Sakarya Ferizli State Hosp, Clin Internal Med, Sakarya, Turkiye
1 shared publication
Latest Publications
- 1 May 2024
- Published by SAGE Publications in Metabolic Syndrome and Related Disorders
- Vol. 22 (4) , 295-301
Comparison of Two Estimated Glucose Disposal Rate Methods for Detecting Insulin Resistance in Adults with Type 1 Diabetes Mellitus
Background: The presence of insulin resistance (IR) in patients with type 1 diabetes mellitus (T1DM) is a significant indicator of all chronic diabetic complications, independent of other risk factors. The estimated glucose disposal rate (eGDR) is a practical method that can be easily used in daily practice to determine IR. This study aimed to determine the cutoff values for two eGDR methods and compare their diagnostic value for determining IR in adult T1DM patients with metabolic syndrome (MetS). Methods: This cross-sectional study was performed on 184 adults admitted to the endocrinology outpatient clinic diagnosed with T1DM. Demographic characteristics, anthropometric measurements, and the presence of hypertension (HT) were recorded. The eGDR of all patients was calculated using two formulas based on HbA1c level, presence of HT, waist-to-hip ratio (WHR), or waist circumference (WC). Diagnostic cutoff values for both eGDRs were defined using receiver operating characteristic (ROC) analysis. Patients were divided into two groups according to the cutoff values. The accuracy of the diagnostic cutoffs for eGDRwhr and eGDRwc was compared using a Bland-Altman plot. Results: The cutoff value for eGDRwhr was 7.37 mg/(kg·min) with 83.3% specificity and 86.7% sensitivity [area under the curve (AUC) = 0.901; P < 0.001; 95% confidence interval (CI), 0.824-0.977] and for eGDRwc 7.50 mg/(kg·min) with 79.8% specificity and 83.3% sensitivity (AUC = 0.895; P < 0.001; 95% CI, 0.817-0.972) for the presence of MetS. Further ROC analysis showed that the difference between the two AUCs (0.901 and 0.895) was not significant (P = 0.923). Conclusion: Assessment of eGDR would lead to early prevention of diabetic complications. eGDR is measured using either WHR or WC. This study is the first to compare WHR and WC in calculating eGDR in adults. WHR and WC are not superior to each other for calculating eGDR in determining IR in T1DM.
- 1 May 2024
- Published by SAGE Publications in Metabolic Syndrome and Related Disorders
- Vol. 22 (4) , 295-301
Comparison of Two Estimated Glucose Disposal Rate Methods for Detecting Insulin Resistance in Adults with Type 1 Diabetes Mellitus
Background: The presence of insulin resistance (IR) in patients with type 1 diabetes mellitus (T1DM) is a significant indicator of all chronic diabetic complications, independent of other risk factors. The estimated glucose disposal rate (eGDR) is a practical method that can be easily used in daily practice to determine IR. This study aimed to determine the cutoff values for two eGDR methods and compare their diagnostic value for determining IR in adult T1DM patients with metabolic syndrome (MetS). Methods: This cross-sectional study was performed on 184 adults admitted to the endocrinology outpatient clinic diagnosed with T1DM. Demographic characteristics, anthropometric measurements, and the presence of hypertension (HT) were recorded. The eGDR of all patients was calculated using two formulas based on HbA1c level, presence of HT, waist-to-hip ratio (WHR), or waist circumference (WC). Diagnostic cutoff values for both eGDRs were defined using receiver operating characteristic (ROC) analysis. Patients were divided into two groups according to the cutoff values. The accuracy of the diagnostic cutoffs for eGDRwhr and eGDRwc was compared using a Bland-Altman plot. Results: The cutoff value for eGDRwhr was 7.37 mg/(kg·min) with 83.3% specificity and 86.7% sensitivity [area under the curve (AUC) = 0.901; P < 0.001; 95% confidence interval (CI), 0.824-0.977] and for eGDRwc 7.50 mg/(kg·min) with 79.8% specificity and 83.3% sensitivity (AUC = 0.895; P < 0.001; 95% CI, 0.817-0.972) for the presence of MetS. Further ROC analysis showed that the difference between the two AUCs (0.901 and 0.895) was not significant (P = 0.923). Conclusion: Assessment of eGDR would lead to early prevention of diabetic complications. eGDR is measured using either WHR or WC. This study is the first to compare WHR and WC in calculating eGDR in adults. WHR and WC are not superior to each other for calculating eGDR in determining IR in T1DM.
- 27 September 2023
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 61 (4) , 292-296
The Relationship Between Peyronie’s Disease and Serum Parathormone and Ionized Calcium Levels?
- 27 September 2023
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 61 (4) , 292-296
The Relationship Between Peyronie’s Disease and Serum Parathormone and Ionized Calcium Levels?
- 23 June 2023
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 61 (3) , 146-153
New Cut-off Value for Low-Dose Acth Stimulation Test in the Diagnosis of Adrenal Insufficiency
- 23 June 2023
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 61 (3) , 146-153
New Cut-off Value for Low-Dose Acth Stimulation Test in the Diagnosis of Adrenal Insufficiency
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (11) , e20230406
The effects of adequate dietary calcium intake in patients with hypoparathyroidism non-adherent to treatment: a prospective randomized controlled trial
A significant problem that compels clinicians in the conventional treatment of hypoparathyroidism is patients’ non-adherence to treatment. This study aimed to evaluate the effects of adequate Ca intake with dietary recommendations among hypoparathyroidism patients who persistently use Ca supplementation irregularly on plasma Ca and phosphate levels.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (11) , e20230406
Open AccessThe effects of adequate dietary calcium intake in patients with hypoparathyroidism non-adherent to treatment: a prospective randomized controlled trial
A significant problem that compels clinicians in the conventional treatment of hypoparathyroidism is patients’ non-adherence to treatment. This study aimed to evaluate the effects of adequate Ca intake with dietary recommendations among hypoparathyroidism patients who persistently use Ca supplementation irregularly on plasma Ca and phosphate levels.
- Open Access
- 1 January 2023
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- Vol. 57 (3) , 332-338
Assessment of Health-Related Quality of Life in Patients with Idiopathic Hirsutism Compared to Patients with Polycystic Ovary Syndrome
Objective: Hirsutism affects 5-15% of women of reproductive age. Health-related quality of life (HQOL) is a multidimensional assessment of well-being that considers the physical, social, and emotional aspects associated with a specific disease. The aim of this study is to evaluate HQOL in patients diagnosed with idiopathic hirsutism (IH) and compare it with patients diagnosed with polycystic ovary syndrome (PCOS).Methods: This cross-sectional observational study was performed on 183 female individuals, consisting of 51 patients diagnosed with idiopathic hirsutism, 76 patients diagnosed with PCOS, and 56 healthy volunteers. Participants with a history of neuropsychiatric disorders, under 18 and over 45 years of age, during pregnancy and lactation, with any chronic disease that could interfere with diag-nostic laboratory tests, and who had previously been treated for IH or PCOS were excluded from the study. Demographic, anthropo-metric, laboratory, and clinical data on the cases were recorded. The Short Form-36 (SF-36) questionnaire, the Beck Depression Inven-tory (BDI), and the Beck Anxiety Inventory (BAI) were administered in a face-to-face interview by related authors involved in the study.Results: The mean age, level of education, lifestyle, and marital status of all three groups were similar. There were no significant differ-ences in body mass index (BMI) or waist circumference between the groups. Mean modified Ferriman-Gallwey (mFG) scores were similar in the IH and PCOS groups. In the IH patients, the general health and mental health domains of the SF-36 questionnaire scores were sig-nificantly lower than in the control group (p<0.001 and p=0.026, respectively). When the SF-36 questionnaire scores were compared be-tween the IH and PCOS groups, the general health and role emotional domains were significantly lower in the PCOS group (p=0.013 and p<0.001, respectively), and the other domains were similar. All SF-36 questionnaire domains were significantly and negatively correlated with BMI and waist circumference measurements in IH patients. Both BDI and BAI scores were significantly and positively correlated with BMI (r=0.348, p<0.001, and r=0.162, p=0.012, respectively) and waist circumference (r=0.326, p<0.001, and r=0.344, p<0.001, respective-ly). Six out of eight domains of the SF-36 QOL scores were significantly and negatively correlated with the mFG scores.Conclusion: Patients diagnosed with IH have impaired HQOL, similar to patients diagnosed with PCOS. Improving HQOL should be a goal when deciding on a management approach for hirsutism, which is one of the most common reasons for referral to endo-crinology and dermatology outpatient clinics.
- 1 January 2023
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- Vol. 57 (3) , 332-338
Open AccessAssessment of Health-Related Quality of Life in Patients with Idiopathic Hirsutism Compared to Patients with Polycystic Ovary Syndrome
Objective: Hirsutism affects 5-15% of women of reproductive age. Health-related quality of life (HQOL) is a multidimensional assessment of well-being that considers the physical, social, and emotional aspects associated with a specific disease. The aim of this study is to evaluate HQOL in patients diagnosed with idiopathic hirsutism (IH) and compare it with patients diagnosed with polycystic ovary syndrome (PCOS).Methods: This cross-sectional observational study was performed on 183 female individuals, consisting of 51 patients diagnosed with idiopathic hirsutism, 76 patients diagnosed with PCOS, and 56 healthy volunteers. Participants with a history of neuropsychiatric disorders, under 18 and over 45 years of age, during pregnancy and lactation, with any chronic disease that could interfere with diag-nostic laboratory tests, and who had previously been treated for IH or PCOS were excluded from the study. Demographic, anthropo-metric, laboratory, and clinical data on the cases were recorded. The Short Form-36 (SF-36) questionnaire, the Beck Depression Inven-tory (BDI), and the Beck Anxiety Inventory (BAI) were administered in a face-to-face interview by related authors involved in the study.Results: The mean age, level of education, lifestyle, and marital status of all three groups were similar. There were no significant differ-ences in body mass index (BMI) or waist circumference between the groups. Mean modified Ferriman-Gallwey (mFG) scores were similar in the IH and PCOS groups. In the IH patients, the general health and mental health domains of the SF-36 questionnaire scores were sig-nificantly lower than in the control group (p<0.001 and p=0.026, respectively). When the SF-36 questionnaire scores were compared be-tween the IH and PCOS groups, the general health and role emotional domains were significantly lower in the PCOS group (p=0.013 and p<0.001, respectively), and the other domains were similar. All SF-36 questionnaire domains were significantly and negatively correlated with BMI and waist circumference measurements in IH patients. Both BDI and BAI scores were significantly and positively correlated with BMI (r=0.348, p<0.001, and r=0.162, p=0.012, respectively) and waist circumference (r=0.326, p<0.001, and r=0.344, p<0.001, respective-ly). Six out of eight domains of the SF-36 QOL scores were significantly and negatively correlated with the mFG scores.Conclusion: Patients diagnosed with IH have impaired HQOL, similar to patients diagnosed with PCOS. Improving HQOL should be a goal when deciding on a management approach for hirsutism, which is one of the most common reasons for referral to endo-crinology and dermatology outpatient clinics.
- Open Access
- 1 January 2023
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- Vol. 57 (2) , 250-256
The Role of Serum Inflammation-Based Scores in Diagnosis and Assessing Remission in Cushing’s Disease
Objectives: Chronic hypercortisolism causes diverse alterations in the immune system and inflammatory disruptions. Serum in-flammation-based scores (SIBS) are indicators of systemic inflammatory status. This study aims to determine the role of SIBS in the diagnosis and evaluation of remission in patients with Cushing's disease (CD).Methods: This retrospective cross-sectional study was conducted on 195 participants; 52 patients diagnosed and followed up after treatment with CD, 65 patients with subclinical Cushing's syndrome (SCS), and 78 healthy individuals whose complete blood counts (CBC) were obtained for analysis. Participants with additional diseases or drug use that could affect CBC were excluded from the study. SIBS of the three groups were compared. Scores considered were neutrophil-to-lymphocyte ratio (NLR), mono-cyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII). The correla-tions between SIBS and initial diagnostic tests for hypercortisolism were analyzed. The SIBS of patients with CD at the diagnosis were compared with those after remission. In addition, receiver operator characteristic curve analyses were used to determine the diagnostic accuracy, specificity, and sensitivity of the scores significantly high in the CD group.Results: MLR and SII values were significantly higher in CD patients than in the healthy group (p<0.01). NLR and SII were signifi-cantly higher in patients with CD than those with SCS (p<0.05). There were no significant differences between the SCS and the control groups in all SIBS. We determine significant, positive, and moderately correlated findings between SIBS and initial diag-nostic tests for hypercortisolism in the CD group (0.300.70; p<0.05). All of the scores evaluated were significantly lower in the remission of the disease compared to the active period (p<0.001). An optimal cut-off MLR value of 0.20 showed the best diagnostic value (p=0.003; sensitivity, 78.4%; specificity, 51.4%), and an optimal cut-off SII value of 776.20 showed the best diagnostic value (p=0.017; sensitivity, 54.9%; specificity, 70.0%).Conclusion: The SIBS, which can be easily calculated with the data obtained from CBC and do not have additional costs, can con-tribute to the diagnosis and assessment of remission in patients with CD.
- 1 January 2023
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- Vol. 57 (2) , 250-256
Open AccessThe Role of Serum Inflammation-Based Scores in Diagnosis and Assessing Remission in Cushing’s Disease
Objectives: Chronic hypercortisolism causes diverse alterations in the immune system and inflammatory disruptions. Serum in-flammation-based scores (SIBS) are indicators of systemic inflammatory status. This study aims to determine the role of SIBS in the diagnosis and evaluation of remission in patients with Cushing's disease (CD).Methods: This retrospective cross-sectional study was conducted on 195 participants; 52 patients diagnosed and followed up after treatment with CD, 65 patients with subclinical Cushing's syndrome (SCS), and 78 healthy individuals whose complete blood counts (CBC) were obtained for analysis. Participants with additional diseases or drug use that could affect CBC were excluded from the study. SIBS of the three groups were compared. Scores considered were neutrophil-to-lymphocyte ratio (NLR), mono-cyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII). The correla-tions between SIBS and initial diagnostic tests for hypercortisolism were analyzed. The SIBS of patients with CD at the diagnosis were compared with those after remission. In addition, receiver operator characteristic curve analyses were used to determine the diagnostic accuracy, specificity, and sensitivity of the scores significantly high in the CD group.Results: MLR and SII values were significantly higher in CD patients than in the healthy group (p<0.01). NLR and SII were signifi-cantly higher in patients with CD than those with SCS (p<0.05). There were no significant differences between the SCS and the control groups in all SIBS. We determine significant, positive, and moderately correlated findings between SIBS and initial diag-nostic tests for hypercortisolism in the CD group (0.300.70; p<0.05). All of the scores evaluated were significantly lower in the remission of the disease compared to the active period (p<0.001). An optimal cut-off MLR value of 0.20 showed the best diagnostic value (p=0.003; sensitivity, 78.4%; specificity, 51.4%), and an optimal cut-off SII value of 776.20 showed the best diagnostic value (p=0.017; sensitivity, 54.9%; specificity, 70.0%).Conclusion: The SIBS, which can be easily calculated with the data obtained from CBC and do not have additional costs, can con-tribute to the diagnosis and assessment of remission in patients with CD.
- 24 March 2021
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (7) , e14181
Risk of hypercalcemia in patients with very high serum 25‐OH vitamin D levels
Objective We aimed to evaluate the risk of hypercalcemia in patients with very high levels of 25‐hydroxy vitamin D (25(OH)D). Methods The distribution of patients who were screened for 25(OH)D in our hospital between January 2014 and December 2018 was evaluated and patients with serum concentrations of 25(OH)D>88 ng/ml were selected. Then, biochemical parameters of the cases with 25(OH)D>88 ng/ml were compared according to calcium status, vitamin D level (group 1, 88‐100 ng/ml; group 2, 100‐150 ng/ml and group 3, >150 ng/ml), and gender. Results A total of 282,932 patients who underwent 25(OH)D tests in our hospital were evaluated. A total of 1,311 (0.5 %) patients had very high 25(OH)D levels (>88 ng/ml). 495 patients who met our inclusion criteria and had complete data participated in the study. The median age was 58 years (interquartile range [IQR] = 41–71 years) and the median level of 25(OH)D was 104.6 mg/ml (IQR = 94.9–124.9 ng/ml). Most of the subjects (83.7%) with very high 25(OH)D levels were normocalcemic. A weak inverse correlation was observed between 25(OH)D level and intact parathyroid hormone (iPTH) level (r=–0.118, p=0.01), but no correlation between 25(OH)D and calcium levels was observed. Alkaline phosphatase (ALP) levels were significantly higher in males (p = 0.032), and age and iPTH levels were higher in females (p<0.001 and p=0.004). ALP, phosphorus levels, and iPTH suppression rates were higher in hypercalcemic patients (p<0.001, p<0.001, and p<0.001, respectively), while the iPTH level was significantly lower in hypercalcemic patients (p<0.001) than in normocalcemic patients. Among the three groups with different 25(OH)D levels, no difference was found in levels of iPTH, calcium, phosphorus, ALP, or age. Conclusion Most patients with very high vitamin D levels were normocalcemic, but severe hypercalcemia was also observed. Vitamin D replacement therapy and follow‐up should be done according to clinical guideline recommendations.
- 24 March 2021
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (7) , e14181
Risk of hypercalcemia in patients with very high serum 25‐OH vitamin D levels
Objective We aimed to evaluate the risk of hypercalcemia in patients with very high levels of 25‐hydroxy vitamin D (25(OH)D). Methods The distribution of patients who were screened for 25(OH)D in our hospital between January 2014 and December 2018 was evaluated and patients with serum concentrations of 25(OH)D>88 ng/ml were selected. Then, biochemical parameters of the cases with 25(OH)D>88 ng/ml were compared according to calcium status, vitamin D level (group 1, 88‐100 ng/ml; group 2, 100‐150 ng/ml and group 3, >150 ng/ml), and gender. Results A total of 282,932 patients who underwent 25(OH)D tests in our hospital were evaluated. A total of 1,311 (0.5 %) patients had very high 25(OH)D levels (>88 ng/ml). 495 patients who met our inclusion criteria and had complete data participated in the study. The median age was 58 years (interquartile range [IQR] = 41–71 years) and the median level of 25(OH)D was 104.6 mg/ml (IQR = 94.9–124.9 ng/ml). Most of the subjects (83.7%) with very high 25(OH)D levels were normocalcemic. A weak inverse correlation was observed between 25(OH)D level and intact parathyroid hormone (iPTH) level (r=–0.118, p=0.01), but no correlation between 25(OH)D and calcium levels was observed. Alkaline phosphatase (ALP) levels were significantly higher in males (p = 0.032), and age and iPTH levels were higher in females (p<0.001 and p=0.004). ALP, phosphorus levels, and iPTH suppression rates were higher in hypercalcemic patients (p<0.001, p<0.001, and p<0.001, respectively), while the iPTH level was significantly lower in hypercalcemic patients (p<0.001) than in normocalcemic patients. Among the three groups with different 25(OH)D levels, no difference was found in levels of iPTH, calcium, phosphorus, ALP, or age. Conclusion Most patients with very high vitamin D levels were normocalcemic, but severe hypercalcemia was also observed. Vitamin D replacement therapy and follow‐up should be done according to clinical guideline recommendations.
- 8 June 2017
- Published by Yerkure Tanitim ve Yayincilik Hizmetleri in Endouroloji Bulteni
- p. 34-36
Radikal Prostatektomi Sonrası Mesane Boynu Darlıklarına Yaklaşım
- 8 June 2017
- Published by Yerkure Tanitim ve Yayincilik Hizmetleri in Endouroloji Bulteni
- p. 34-36
Radikal Prostatektomi Sonrası Mesane Boynu Darlıklarına Yaklaşım
- 13 August 2016
- Published by Springer Nature in International Urology and Nephrology
- Vol. 48 (11) , 1789-1795
Vitamin D3 deficiency is associated with female sexual dysfunction in premenopausal women
Purpose To assess female sexual functions in women who were affected by vitamin D3 deficiency. Methods A total of 50 women with FSD and 58 healthy women controls were included in the study, according to the Female Sexual Function Index (FSFI) questionnaire using a 26.55 cutoff value. Detailed medical histories were obtained from all sexual active women, and all women were evaluated in terms of possible presence of depression with the Beck Depression Inventory (BDI). Serum 25-hydroxyvitamin D3, follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, total and free testosterone, estradiol, dehydroepiandrosterone-SO4 (DHEA-SO4), sex hormone-binding globulin (SHBG), free thyroxine (fT4), and thyroid-stimulating hormone (TSH) levels were measured. Results Mean age of premenopausal women was 34.9 ± 6.3 years. The level of serum 25-hydroxyvitamin D3 was significantly lower in women with FSD compared with the controls (15.9 ± 8.4 and 26.3 ± 11.7 nmol/L, respectively). Desire (p = 0.0001), arousal (p = 0.0001), lubrication (p = 0.002), orgasm (p = 0.0001), satisfaction (p = 0.018), and pain (p = 0.010) domain scores were also correlated with the levels of serum 25-hydroxyvitamin D3. The BDI score showed a significant negative correlation with the total FSFI score (r = −0.492, p = 0.0001). The FSFI score not showed a significant correlation with the hormones (p > 0.05). Conclusion There is a relationship with FSD and deficiency of vitamin D3. Also, increased depressive symptoms were associated with FSD.
- 13 August 2016
- Published by Springer Nature in International Urology and Nephrology
- Vol. 48 (11) , 1789-1795
Vitamin D3 deficiency is associated with female sexual dysfunction in premenopausal women
Purpose To assess female sexual functions in women who were affected by vitamin D3 deficiency. Methods A total of 50 women with FSD and 58 healthy women controls were included in the study, according to the Female Sexual Function Index (FSFI) questionnaire using a 26.55 cutoff value. Detailed medical histories were obtained from all sexual active women, and all women were evaluated in terms of possible presence of depression with the Beck Depression Inventory (BDI). Serum 25-hydroxyvitamin D3, follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, total and free testosterone, estradiol, dehydroepiandrosterone-SO4 (DHEA-SO4), sex hormone-binding globulin (SHBG), free thyroxine (fT4), and thyroid-stimulating hormone (TSH) levels were measured. Results Mean age of premenopausal women was 34.9 ± 6.3 years. The level of serum 25-hydroxyvitamin D3 was significantly lower in women with FSD compared with the controls (15.9 ± 8.4 and 26.3 ± 11.7 nmol/L, respectively). Desire (p = 0.0001), arousal (p = 0.0001), lubrication (p = 0.002), orgasm (p = 0.0001), satisfaction (p = 0.018), and pain (p = 0.010) domain scores were also correlated with the levels of serum 25-hydroxyvitamin D3. The BDI score showed a significant negative correlation with the total FSFI score (r = −0.492, p = 0.0001). The FSFI score not showed a significant correlation with the hormones (p > 0.05). Conclusion There is a relationship with FSD and deficiency of vitamin D3. Also, increased depressive symptoms were associated with FSD.